Louise Fraser, Nasreen Parkar, Amina Powell, Mark Richardson
{"title":"Interpretation and implementation of adult diagnostic reference levels in nuclear medicine and PET in the UK.","authors":"Louise Fraser, Nasreen Parkar, Amina Powell, Mark Richardson","doi":"10.1097/MNM.0000000000001953","DOIUrl":null,"url":null,"abstract":"<p><p>In the UK, the Administration of Radioactive Substances Advisory Committee (ARSAC) sets and publishes National Diagnostic Reference Levels (NDRLs) for diagnostic nuclear medicine (NM) and Positron Emission Tomography procedures. This article summarises how these NDRLs should be applied and used within the UK and proposes a new model on how they are set. As an exemplar, the results of a recent survey of administered activities in the UK for 18 F-fluorodeoxyglucose (FDG) for whole-body tumour imaging and infection inflammation imaging are presented here. ARSAC recommends that the UK NDRLs for NM or PET examinations are set as either a fixed activity (MBq) or by administered activity per body weight (MBq/kg). ARSAC proposes setting the first weight-based activity scaling NDRLs for 18 F-FDG whole-body tumour imaging and 18 F-FDG infection inflammation imaging to 3.5 MBq/kg.</p>","PeriodicalId":19708,"journal":{"name":"Nuclear Medicine Communications","volume":" ","pages":"379-383"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964192/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear Medicine Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MNM.0000000000001953","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
In the UK, the Administration of Radioactive Substances Advisory Committee (ARSAC) sets and publishes National Diagnostic Reference Levels (NDRLs) for diagnostic nuclear medicine (NM) and Positron Emission Tomography procedures. This article summarises how these NDRLs should be applied and used within the UK and proposes a new model on how they are set. As an exemplar, the results of a recent survey of administered activities in the UK for 18 F-fluorodeoxyglucose (FDG) for whole-body tumour imaging and infection inflammation imaging are presented here. ARSAC recommends that the UK NDRLs for NM or PET examinations are set as either a fixed activity (MBq) or by administered activity per body weight (MBq/kg). ARSAC proposes setting the first weight-based activity scaling NDRLs for 18 F-FDG whole-body tumour imaging and 18 F-FDG infection inflammation imaging to 3.5 MBq/kg.
期刊介绍:
Nuclear Medicine Communications, the official journal of the British Nuclear Medicine Society, is a rapid communications journal covering nuclear medicine and molecular imaging with radionuclides, and the basic supporting sciences. As well as clinical research and commentary, manuscripts describing research on preclinical and basic sciences (radiochemistry, radiopharmacy, radiobiology, radiopharmacology, medical physics, computing and engineering, and technical and nursing professions involved in delivering nuclear medicine services) are welcomed, as the journal is intended to be of interest internationally to all members of the many medical and non-medical disciplines involved in nuclear medicine. In addition to papers reporting original studies, frankly written editorials and topical reviews are a regular feature of the journal.